4.8 Review

Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 126, 期 9, 页码 3165-3175

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI84418

关键词

-

资金

  1. Public Health Service grants from the National Cancer Institute (NCI) [CA019014, CA163217, DE018304, DE023946, DE018281, CA096500]
  2. Institute of Dental and Craniofacial Research (NIDCR)

向作者/读者索取更多资源

Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. This human gammaherpesvirus was discovered in 1994 by Drs. Yuan Chang and Patrick Moore. Today, there are over five thousand publications on KSHV and its associated malignancies. In this article, we review recent and ongoing developments in the KSHV field, including molecular mechanisms of KSHV pathogenesis, clinical aspects of KSHV-associated diseases, and current treatments for cancers associated with this virus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据